This series is provided by .jpg)
To complete the on-line evaluation and credit request form and to print your certificate, choose the appropriate link:
The Outcome Tool Survey is now available for "Managing Rheumatoid Arthritis in the Primary Care Setting" participants
Physician CME "Snack" Survey CME Snacks are defined as continuing education activities certified/designated for less than 1.0 CME credit.
Biologics are an important therapeutic option for treating patients with rheumatoid arthritis, as they can target specific immunologic components that are thought to be involved in the pathogenesis of RA. However, they are associated with rare but severe adverse events such as serious infections, lymphoma, or chronic heart failure. When assessing the comparative efficacy and safety of biologic agents for RA, one must understand the current safety issues with biologic agents, including FDA black box warnings, and current screening and /or patient selection recommendations for the safety of RA patients to improve outcomes. The safety of these agents should be as important to the clinician making therapeutic decisions as information about efficacy.
This program will review indications for biologic use; contraindications, biologic safety issues, and risk reduction strategies.
Target Audience
This program is intended for family practitioners, general internists, advanced nurse practitioners, physician assistants and other healthcare providers.
Program Objectives
- Review the role of primary care in the management of rheumatoid arthritis (RA) and its comorbidities
- Identify the clinical characteristics of RA and the concept of pattern recognition as it applies to chronic inflammatory arthritis
- Identify histologic, anatomic, and physiologic considerations that contribute to the pathogenesis of RA
- Describe treatment goals and/or outcome measures for managing RA
- Devise strategies for implementing RA therapies to maximize their safety and efficacy
- Apply evidence and best practices to manage the complexities of RA in the primary care setting
- Describe the systemic complications of RA and integrate the treatment of comorbidities into patients' overall treatment plan
Faculty
John J. Cush, MD
Director of Clinical Rheumatology
Baylor Research Institute
Professor of Medicine and Rheumatology
Baylor University Medical Center
Clinical Professor of Internal Medicine
University of Texas Southwestern Medical Center
Dallas, Texas
Robin A. Hall, DO
Private Practice
Destination Health
Southlake, Texas
Assistant Clinical Professor
Department of Family Practice
University of North Texas Health Science Center
Fort Worth, Texas
Release and Termination Dates
Release: Thursday, March 11, 2010
12:00 PM - 12:30 PM ET
Termination: Thursday, March 10, 2011
Accreditation
Physician
The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Texas Southwestern Medical Center designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing
The Camenae Group, Inc, is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This activity meets Type I criteria for mandatory continuing education requirements toward relicensure as established by the Board of Nursing.
The Camenae Group, Inc. provides up to 4.5 contact hours for successful completion of this educational activity (0.5 contact hours for each Part).
This activity is supported by educational donations provided by Amgen and Pfizer Inc.
|
